Playback speed
10 seconds
ESMO Breast 2024 Insights: "FeDeriCa Trial Final Analysis - Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection + Chemo in HER2+ eBC"
263 views
June 21, 2024
Comments 0
Login to view comments.
Click here to Login
Related Videos
AUTOPLAY